BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22995853)

  • 21. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.
    Senerchia AA; Ribeiro KB; Rodriguez-Galindo C
    Pediatr Blood Cancer; 2014 Feb; 61(2):211-6. PubMed ID: 24174376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
    Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
    Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
    Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
    J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
    J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
    Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
    J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
    Shaikh WR; Xiong M; Weinstock MA
    Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
    Bagaria SP; Ray PS; Joseph RW; Heckman MG; Rawal B; Gray RJ; Pockaj B; Wasif N
    Cancer; 2013 May; 119(10):1860-7. PubMed ID: 23408288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database.
    Rueth NM; Groth SS; Tuttle TM; Virnig BA; Al-Refaie WB; Habermann EB
    Ann Surg Oncol; 2010 Jun; 17(6):1662-8. PubMed ID: 20165985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study.
    Feigelson HS; Powers JD; Kumar M; Carroll NM; Pathy A; Ritzwoller DP
    Cancer Med; 2019 Aug; 8(9):4508-4516. PubMed ID: 31215776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
    Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
    JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007.
    Feng Z; Wu X; Chen V; Velie E; Zhang Z
    J Cutan Pathol; 2011 Aug; 38(8):616-24. PubMed ID: 21518379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left-sided excess of invasive cutaneous melanoma in six countries.
    Brewster DH; Horner MJ; Rowan S; Jelfs P; de Vries E; Pukkala E
    Eur J Cancer; 2007 Dec; 43(18):2634-7. PubMed ID: 17988856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superficial Spreading Melanomas in Children: An Analysis of Outcomes Using the Surveillance, Epidemiology, and End Results (SEER) Database.
    Allan BJ; Ovadia S; Tashiro J; Thaller SR
    Ann Plast Surg; 2015 Sep; 75(3):327-31. PubMed ID: 24667880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma thickness trends in the United States, 1988-2006.
    Criscione VD; Weinstock MA
    J Invest Dermatol; 2010 Mar; 130(3):793-7. PubMed ID: 19829301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underuse of wide excision for primary cutaneous melanoma in the United States.
    Haigh PI; Urbach DR
    Am Surg; 2004 Nov; 70(11):942-6. PubMed ID: 15586502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009.
    Shaikh WR; Dusza SW; Weinstock MA; Oliveria SA; Geller AC; Halpern AC
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.